Biliary Tract Neoplasms Active Not Recruiting Phase 3 Trials for Durvalumab (DB11714)

Also known as: Biliary Tract Neoplasm / Neoplasm biliary tract / Biliary neoplasm NOS / Biliary neoplasm / Neoplasm of biliary tract (disorder) / Biliary neoplasia

IndicationStatusPhase
DBCOND0032430 (Biliary Tract Neoplasms)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03875235Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)Treatment